AU2024257451A1 - Method for producing cyclic peptide compound - Google Patents

Method for producing cyclic peptide compound

Info

Publication number
AU2024257451A1
AU2024257451A1 AU2024257451A AU2024257451A AU2024257451A1 AU 2024257451 A1 AU2024257451 A1 AU 2024257451A1 AU 2024257451 A AU2024257451 A AU 2024257451A AU 2024257451 A AU2024257451 A AU 2024257451A AU 2024257451 A1 AU2024257451 A1 AU 2024257451A1
Authority
AU
Australia
Prior art keywords
group
crystal
compound
formula
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024257451A
Other languages
English (en)
Inventor
Takahiro Horibe
Yuuki INOMATA
Junichi Shiina
Yinli Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU2024257451A1 publication Critical patent/AU2024257451A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/306—Extraction; Separation; Purification by precipitation by crystallization
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
AU2024257451A 2023-04-20 2024-04-19 Method for producing cyclic peptide compound Pending AU2024257451A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023-069189 2023-04-20
JP2023069189 2023-04-20
PCT/JP2024/015529 WO2024219480A1 (ja) 2023-04-20 2024-04-19 環状ペプチド化合物の製造方法

Publications (1)

Publication Number Publication Date
AU2024257451A1 true AU2024257451A1 (en) 2025-10-09

Family

ID=93152939

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2024257451A Pending AU2024257451A1 (en) 2023-04-20 2024-04-19 Method for producing cyclic peptide compound

Country Status (9)

Country Link
EP (1) EP4678652A1 (https=)
JP (1) JPWO2024219480A1 (https=)
KR (1) KR20250174064A (https=)
CN (1) CN120936619A (https=)
AU (1) AU2024257451A1 (https=)
IL (1) IL323506A (https=)
MX (1) MX2025012255A (https=)
TW (1) TW202506706A (https=)
WO (1) WO2024219480A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025240847A1 (en) 2024-05-17 2025-11-20 Revolution Medicines, Inc. Ras inhibitors
US20250375445A1 (en) 2024-06-07 2025-12-11 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
WO2025265060A1 (en) 2024-06-21 2025-12-26 Revolution Medicines, Inc. Therapeutic compositions and methods for managing treatment-related effects
WO2026006747A1 (en) 2024-06-28 2026-01-02 Revolution Medicines, Inc. Ras inhibitors
WO2026015801A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015796A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015825A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Use of ras inhibitor for treating pancreatic cancer
WO2026015790A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026050446A1 (en) 2024-08-29 2026-03-05 Revolution Medicines, Inc. Ras inhibitors
WO2026072904A2 (en) 2024-09-26 2026-04-02 Revolution Medicines, Inc. Compositions and methods for treating lung cancer
CN119751564B (zh) * 2024-12-05 2025-11-11 浙江大学 一种环肽化合物合成方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9506372D0 (en) * 1995-03-29 1995-05-17 Fujisawa Pharmaceutical Co New peptide compounds
KR20210139366A (ko) 2019-03-15 2021-11-22 추가이 세이야쿠 가부시키가이샤 방향족 아미노산 유도체의 제조 방법
JPWO2022138891A1 (https=) * 2020-12-25 2022-06-30
TW202309065A (zh) * 2021-05-07 2023-03-01 日商中外製藥股份有限公司 包含n-取代胺基酸殘基之環狀化合物的製造方法
AR125796A1 (es) 2021-05-07 2023-08-16 Chugai Pharmaceutical Co Ltd Compuesto cíclico que tiene una acción inhibitoria selectiva en kras sobre hras y nras
AU2022270498A1 (en) * 2021-05-07 2023-10-05 Chugai Seiyaku Kabushiki Kaisha Preparation containing cyclic peptide compound and method for producing same

Also Published As

Publication number Publication date
IL323506A (en) 2025-11-01
CN120936619A (zh) 2025-11-11
KR20250174064A (ko) 2025-12-11
WO2024219480A1 (ja) 2024-10-24
TW202506706A (zh) 2025-02-16
JPWO2024219480A1 (https=) 2024-10-24
EP4678652A1 (en) 2026-01-14
MX2025012255A (es) 2025-11-03

Similar Documents

Publication Publication Date Title
AU2024257451A1 (en) Method for producing cyclic peptide compound
TW202309065A (zh) 包含n-取代胺基酸殘基之環狀化合物的製造方法
JP7766028B2 (ja) 高難度配列の効率的ペプチド縮合法
TWI873263B (zh) 胜肽化合物的合成法
CN114630835B (zh) 包含空间位阻大的氨基酸的肽化合物的制备方法
EP4269422A1 (en) Method for producing peptide compound containing n-substituted-amino acid residue
CN116547295A (zh) 氨基酸向固相合成用树脂的担载方法
CA3237911A1 (en) Method for producing n-alkyl amino acid and peptide including n-alkyl amino acid
TW202229306A (zh) 抑制由二酮哌嗪形成所導致之缺陷的胜肽合成方法
TW202409059A (zh) 抑制由二酮哌嗪形成之缺陷的胜肽合成方法
Prasad et al. Crystal and molecular structure of benzyloxycarbonyl‐α‐aminoisobutyryl‐l‐prolyl methylamide: The observation of an X2‐Pro3 Type III β‐Turn
CN105658670A (zh) 肽-低聚尿素嵌合化合物及其使用方法
CN120051480A (zh) 用于生产含有n-取代氨基酸残基的环肽化合物的方法
TW202112759A (zh) 肽化合物的製造方法、保護基形成用試藥及縮合多環化合物
Fu et al. Development of a cyclosporin A derivative with excellent anti-hepatitis C virus potency
JP7165289B1 (ja) Ｎ－置換アミノ酸残基を含む環状化合物の製造方法
CN117279928A (zh) 包含n-取代氨基酸残基的环状化合物的制备方法
HK40096738A (zh) 包含n-取代氨基酸残基的环状化合物的制备方法
TW201329087A (zh) 胜肽脫甲醯酶抑制劑
EA049862B1 (ru) Способ получения циклического соединения, содержащего n-замещенный аминокислотный остаток
HK40120616A (zh) 用於生产含有n-取代氨基酸残基的环肽化合物的方法
HK40126783A (zh) 用於产生环肽的共晶的方法
CA3268063A1 (en) Method for producing n-substituted amino acid residue-containing cyclic peptide compound
WO2025192626A1 (ja) 環構造を有するペプチド化合物の製造方法
Yamada et al. Synthesis, crystal structure and molecular conformation of Nα‐Boc‐l‐leucyl‐(Z)‐β‐(3‐pyridyl)‐α, β‐dehydroalanyl‐l‐leucine methyl ester